Case study PK model development for a multi-dose study (Maryland 2)
发布人
打开封面 下载高清视频 观看高清视频 视频下载器
...
Case study PK model development and covariate exploration (Maryland 1)
...
创新药转化PK/PD研究与首次人体试验的剂量设计
...
Case study Implementing a proportional hazard model and calculating hazard ratio
...
Mini case-study #2 Implementing a model with dose-dependent bioavailability
...
Case study Inter-occasion variability and effect of guar gum on alcohol concentr
...
Case study PK modeling workflow on warfarin with Monolix Suite 2018
...
Case study PKPD modeling using the simultaneous, sequential or intermediate appr
...
Mini case study #3 Writing a model for urine data
...
Mini case study #4 Understanding flip-flop kinetics
...
Mini case study time-varying clearance
...
Mini case study Calculating PKPD parameters for an antibiotic
...
Time-to-event modeling with MonolixSuite with a case study on lung cancer surviv
...
Mini case-study Advanced VPC effect of censored data and dropout
...
vet（二）
...
Lecture 4.1- Multi-dose administration
...
vet123（一）
...
ISQP主会场20211205
...
Application of MIDD in New Drug Development 王亚宁
...
新形势下我国新药I期临床试验现状、机遇和挑战
...
Modeling double peaks in plasma concentrations of veralipride
...
Webinar Tumor growth modeling with MonolixSuite - Session 2
...
Modeling of Remifentanil's pharmacokinetics using MonolixSuite
...
Webinar QSP modeling with MonolixSuite - Session 1
...
去美国当医生是怎样的体验？
...
Concentration-QTc modeling with MonolixSuite
...
Webinar QSP modeling with MonolixSuite - Session 2
...
Webinar Tumor growth modeling with MonolixSuite - Session 1
...
Communicating to Influence Drug Development and Regulatory Decisions A Tutorial
...
液质联用技术在靶向代谢组学中的研究进展20211230
...
新冠：发生与防控
...
Lecture 3.1 The straight line model
...
十三分鐘略懂 AI 技術：機器學習、深度學習技術原理及延伸應用
...
《如何设计IND申报中的DMPK研究内容》（2）
...
Communicating to Influence Drug Development and Regulatory Decisions A (2)
...
《如何设计IND申报中的DMPK研究内容》（1）
...
[全英文聊天] 回台灣了- 之後會去哪個國家- 近況更新😘 __ Chen Lily
...
疫情常态化下的在线教学与混合式教学设计
...
在线课程&直播互动——远程在线混合教学策略
...
PKanalix 2019R1_ NCA & CA analysis
...
Lecture 1.4 Pharmacokinetic Models